XML 28 R23.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
NET INCOME PER SHARE
12 Months Ended
Dec. 31, 2019
Earnings Per Share [Abstract]  
NET INCOME PER SHARE NET INCOME PER SHARE

The following table sets forth the calculation of basic and diluted net income per share (in thousands except per share data):

 
Year Ended December 31,
 
2019

2018
 
2017
Numerator:
 
 
 
 
 
Net income
$
314,963

 
$
238,334

 
$
122,695

Denominator:
 

 
 

 
 

Denominator for basic net income per share — weighted-average outstanding shares
36,310

 
36,058

 
33,200

Effect of dilutive securities:
 

 
 

 
 

Stock options, restricted stock awards and restricted stock units
320

 
390

 
359

Denominator for diluted net income per share — weighted-average outstanding shares
36,630

 
36,448

 
33,559

 
 
 
 
 
 
Net income per share — basic 
$
8.67

 
$
6.61

 
$
3.70

Net income per share — diluted 
$
8.60

 
$
6.54

 
$
3.66



The Company’s potentially dilutive securities include outstanding stock options, unvested stock-based awards which include restricted stock awards that vest over a specific service period, restricted stock awards that vest based on achievement of a performance condition, restricted stock awards with a performance and a market condition, restricted stock units and Matching RSUs awarded under the Company's Management Stock Purchase Plan. Shares underlying unvested restricted stock awards that vest based on performance and market conditions that have not been achieved as of the end of the period are not included in the computation of basic or diluted earnings per share. Diluted net income per share considers the impact of potentially dilutive securities except when the inclusion of the potentially dilutive securities would have an anti-dilutive effect.

The following table summarizes the shares underlying the unvested performance-based restricted stock and anti-dilutive securities excluded from the basic and diluted earnings per share calculations (in thousands):

 
Year Ended December 31,
 
2019
 
2018
 
2017
Performance-based restricted stock awards
60

 
53

 
58

Anti-dilutive securities

42

 
100

 
126